A detailed history of Principal Securities, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Principal Securities, Inc. holds 4 shares of IONS stock, worth $135. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Previous 13 69.23%
Holding current value
$135
Previous $620,000 74.19%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$40.06 - $51.86 $360 - $466
-9 Reduced 69.23%
4 $160,000
Q2 2024

Jul 31, 2024

BUY
$36.45 - $47.7 $473 - $620
13 New
13 $620,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.82B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.